Addressing the pressing need for sustainable alternatives to meet the growing global protein demand Hamburg-based biotech startup MicroHarvest has raised €8.5 million in funding.
The new capital will allow the startup to bring its single-cell protein production process to commercialization.
The Series A round was led by Astanor Ventures and Happiness Capital and backed by Faber and existing investor FoodLabs.
The platform will use the fresh funding to grow its R&D team, construct a pilot plant in Lisbon and accelerate toward commercial-scale production.
The German startup is tackling the growing demand for alternative protein ingredients for human food, a $14 billion market.
It aims to provide better, healthier, and tastier protein, produced sustainably using the power of microorganisms.
With their production system for single-cell protein, they address the pressing need for sustainable alternatives to meet the growing global protein demand.
The company claims its proprietary technology enables the production of protein using bacteria at a speed and efficiency that greatly exceeds existing approaches.
Being able to ramp up production quickly is key to becoming a relevant player in the B2B ingredients market.
It enables decentralized production of sustainable, nutritious, high-quality, and safe protein.
Read more on Tech Gist Africa: